|
|
Article: Medicines Company Raises $32.8M For Angiomax Growth.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
The Medicines Co. said it raised $32.8 million through a public offering, with plans for the funds to include developing its approved product Angiomax in other indications.
Parsippany, N.J.-based The Medicines Co. sold 4 million shares at a negotiated price of $8.20 per share. Bear, Stearns & Co. is underwriting the offering.
The Medicines Co.'s stock (NASDAQ:MDCO) rose 35 cents Friday to close at $9.77.
The company is in an SEC-imposed quiet period and officials could not comment on the offering.
In its prospectus, filed in April pertaining to a shelf offering of up to 4 million shares, the company said ...